How to Buy eris Shares on Fincept?
You can buy Eris Lifesciences Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Eris Lifesciences Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Eris, including updates on board meetings and corporate actions.
Eris Lifesciences Limited - https://www.eris.co.in
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
Eris Lifesciences Limited Share Price Today
1,183.00
OPEN
1,215.75
HIGH
1,175.90
LOW
1,193.40
CLOSE
59 K
VOLUME
18,301 Cr
Market Cap
191771
Average Volume
Healthcare
Sector
NSI
Exchange
Eris Lifesciences Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: ERIS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Eris Lifesciences Limited |
ERIS |
INE406M01024 |
Annual General Meeting |
17 Sep 2024 |
1 |
N/A |
Eris Lifesciences Limited |
ERIS |
INE406M01024 |
Annual General Meeting |
15 Sep 2023 |
1 |
N/A |
Eris Lifesciences Limited |
ERIS |
INE406M01024 |
Annual General Meeting |
23 Aug 2022 |
1 |
N/A |
Eris Lifesciences Limited |
ERIS |
INE406M01024 |
Interim Dividend- Rs 7.35 Per Share |
11 Aug 2022 |
1 |
N/A |
Eris Lifesciences Limited |
ERIS |
INE406M01024 |
Annual General Meeting |
23 Aug 2021 |
1 |
N/A |
NSE: ERIS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
ERIS |
24 Dec 2024, 15:39:43 |
Trading Window-XBRL |
N/A |
ERIS |
24 Dec 2024, 15:36:03 |
Trading Window |
N/A |
ERIS |
09 Dec 2024, 18:56:21 |
Alteration Of Capital and Fund Raising-XBRL |
N/A |
ERIS |
09 Dec 2024, 18:55:21 |
Allotment of Securities |
N/A |
ERIS |
05 Dec 2024, 18:38:33 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
NSE: ERIS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Eris Lifesciences Limited |
ERIS |
18 Oct 2024, 18:38:00 |
18 Oct 2024, 18:38:00 |
|
Eris Lifesciences Limited |
ERIS |
17 Jul 2024, 17:35:00 |
17 Jul 2024, 17:35:00 |
|
Eris Lifesciences Limited |
ERIS |
16 Apr 2024, 10:17:00 |
16 Apr 2024, 10:45:00 |
|
Eris Lifesciences Limited |
ERIS |
10 Jan 2024, 18:45:00 |
10 Jan 2024, 19:15:00 |
|
Eris Lifesciences Limited |
ERIS |
17 Oct 2023, 12:45:00 |
17 Oct 2023, 13:15:00 |
NSE: ERIS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Executive Director-MD |
28 Nov 1974 |
27 Jan 2007 |
01250925 |
AMIT INDUBHUSHAN BAKSHI |
Active |
Executive Director |
22 Jun 1971 |
27 Jan 2007 |
01255388 |
INDERJEET SINGH NEGI |
Active |
Executive Director |
12 Jul 1979 |
04 Aug 2020 |
01229038 |
KAUSHAL KAMLESH SHAH |
Active |
Executive Director |
28 Dec 1973 |
20 Dec 2020 |
08976508 |
KRISHNAKUMAR VAIDYANATHAN |
Active |
Independent Director |
22 Sep 1970 |
05 Jan 2021 |
02490816 |
KALPANA VASANTRAI UNADKAT |
Active |
NSE: ERIS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
ERIS |
N/A |
INE406M01024 |
Eris Lifesciences Limited |
22 Oct 2024, 15:54:34 |
Financial Results |
ERIS |
N/A |
INE406M01024 |
Eris Lifesciences Limited |
30 Jul 2024, 18:22:11 |
Financial Results |
ERIS |
N/A |
INE406M01024 |
Eris Lifesciences Limited |
14 May 2024, 20:55:25 |
ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
ERIS |
N/A |
INE406M01024 |
Eris Lifesciences Limited |
06 Feb 2024, 21:45:03 |
ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . |
ERIS |
N/A |
INE406M01024 |
Eris Lifesciences Limited |
01 Nov 2023, 18:37:02 |
NSE: ERIS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
ERIS |
- |
INE406M01024 |
Eris Lifesciences Limited |
22 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
ERIS |
- |
INE406M01024 |
Eris Lifesciences Limited |
30 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Fund Raising |
ERIS |
- |
INE406M01024 |
Eris Lifesciences Limited |
16 May 2024, 00:00:00 |
To consider Fund Raising |
Financial Results |
ERIS |
- |
INE406M01024 |
Eris Lifesciences Limited |
14 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results |
ERIS |
- |
INE406M01024 |
Eris Lifesciences Limited |
06 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
NSE: ERIS Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Tradeand Other Payables Non Current | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 136,105,792.00 | 136,105,792.00 | 25,452,200,000.00 | 27,348,300,000.00 | -20,103,100,000.00 | 54,667,100,000.00 | 833,800,000.00 | -20,103,100,000.00 | 395,900,000.00 | 27,714,700,000.00 | 47,379,900,000.00 | 31,771,500,000.00 | 4,056,800,000.00 | 27,714,700,000.00 | 27,578,700,000.00 | 0.00 | 0.00 | 136,000,000.00 | 136,000,000.00 | 38,447,300,000.00 | 26,104,500,000.00 | 11,800,000.00 | 0.00 | 0.00 | 5,274,300,000.00 | 19,978,300,000.00 | 313,100,000.00 | 19,665,200,000.00 | 780,800,000.00 | 12,342,800,000.00 | 528,700,000.00 | 7,370,000,000.00 | 82,800,000.00 | 7,287,200,000.00 | 626,300,000.00 | 3,155,400,000.00 | 0.00 | 0.00 | 338,000,000.00 | 2,817,400,000.00 | 70,218,800,000.00 | 57,042,200,000.00 | 256,000,000.00 | 0.00 | 2,890,300,000.00 | 520,900,000.00 | 0.00 | 520,900,000.00 | 0.00 | 47,817,800,000.00 | 38,875,200,000.00 | 8,942,600,000.00 | 5,204,400,000.00 | 0.00 | 5,204,400,000.00 | 71,000,000.00 | 5,133,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13,176,600,000.00 | 2,474,600,000.00 | 0.00 | 0.00 | 2,562,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 794,700,000.00 | 0.00 | 4,880,300,000.00 | 0.00 | 0.00 | 2,464,200,000.00 | 964,000,000.00 | 1,500,200,000.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 0.00 | 136,028,280.00 | 136,028,280.00 | 26,411,270,000.00 | 27,812,690,000.00 | -12,374,190,000.00 | 53,213,860,000.00 | -2,300,040,000.00 | -12,374,190,000.00 | 460,020,000.00 | 25,861,190,000.00 | 32,406,260,000.00 | 32,220,310,000.00 | 6,359,120,000.00 | 25,861,190,000.00 | 50,140,000.00 | 25,408,750,000.00 | 182,450,000.00 | 136,030,000.00 | 136,030,000.00 | 38,268,060,000.00 | 12,947,290,000.00 | 13,840,000.00 | 0.00 | 13,840,000.00 | 5,428,180,000.00 | 6,915,260,000.00 | 370,190,000.00 | 6,545,070,000.00 | 527,230,000.00 | 25,320,770,000.00 | 275,800,000.00 | 20,897,430,000.00 | 89,830,000.00 | 20,807,600,000.00 | 620,490,000.00 | 3,313,230,000.00 | 232,810,000.00 | 1,040,000.00 | 395,900,000.00 | 2,683,480,000.00 | 70,488,370,000.00 | 47,467,640,000.00 | 1,750,000.00 | 112,200,000.00 | 3,069,410,000.00 | 157,270,000.00 | 0.00 | 104,010,000.00 | 53,260,000.00 | 38,235,380,000.00 | 29,623,250,000.00 | 8,612,130,000.00 | 5,341,720,000.00 | -1,450,260,000.00 | 6,791,980,000.00 | 295,740,000.00 | 2,047,030,000.00 | 2,067,140,000.00 | 1,989,630,000.00 | 392,440,000.00 | 0.00 | 23,020,730,000.00 | 6,340,000.00 | 13,064,900,000.00 | 1,422,010,000.00 | 1,890,320,000.00 | 10,000.00 | 1,058,190,000.00 | 105,780,000.00 | 726,340,000.00 | 105,910,000.00 | 1,369,590,000.00 | 4,220,240,000.00 | -223,910,000.00 | 4,444,150,000.00 | 941,420,000.00 | 20,000.00 | 941,400,000.00 | 941,400,000.00 |
| 2024-03-31T00:00:00 | annual | 0.00 | 136,028,280.00 | 136,028,280.00 | 26,411,270,000.00 | 27,812,690,000.00 | -12,374,190,000.00 | 53,213,860,000.00 | -2,300,040,000.00 | -12,374,190,000.00 | 460,020,000.00 | 25,861,190,000.00 | 32,406,260,000.00 | 32,220,310,000.00 | 6,359,120,000.00 | 25,861,190,000.00 | 50,140,000.00 | 25,408,750,000.00 | 182,450,000.00 | 136,030,000.00 | 136,030,000.00 | 38,268,060,000.00 | 12,947,290,000.00 | 13,840,000.00 | 0.00 | 13,840,000.00 | 5,428,180,000.00 | 6,915,260,000.00 | 370,190,000.00 | 6,545,070,000.00 | 527,230,000.00 | 25,320,770,000.00 | 275,800,000.00 | 20,897,430,000.00 | 89,830,000.00 | 20,807,600,000.00 | 620,490,000.00 | 3,313,230,000.00 | 232,810,000.00 | 1,040,000.00 | 395,900,000.00 | 2,683,480,000.00 | 70,488,370,000.00 | 47,467,640,000.00 | 1,750,000.00 | 112,200,000.00 | 3,069,410,000.00 | 157,270,000.00 | 0.00 | 104,010,000.00 | 53,260,000.00 | 38,235,380,000.00 | 29,623,250,000.00 | 8,612,130,000.00 | 5,341,720,000.00 | -1,450,260,000.00 | 6,791,980,000.00 | 295,740,000.00 | 2,047,030,000.00 | 2,067,140,000.00 | 1,989,630,000.00 | 392,440,000.00 | 0.00 | 23,020,730,000.00 | 6,340,000.00 | 13,064,900,000.00 | 1,422,010,000.00 | 1,890,320,000.00 | 10,000.00 | 1,058,190,000.00 | 105,780,000.00 | 726,340,000.00 | 105,910,000.00 | 1,369,590,000.00 | 4,220,240,000.00 | -223,910,000.00 | 4,444,150,000.00 | 941,420,000.00 | 20,000.00 | 941,400,000.00 | 941,400,000.00 |
| 2023-09-30T00:00:00 | quarterly | 0.00 | 136,023,248.00 | 136,023,248.00 | 6,131,850,000.00 | 8,295,040,000.00 | 2,561,120,000.00 | 31,974,670,000.00 | 4,640,130,000.00 | 2,561,120,000.00 | 436,050,000.00 | 24,115,680,000.00 | 30,086,060,000.00 | 24,275,730,000.00 | 160,050,000.00 | 24,115,680,000.00 | 23,979,660,000.00 | 0.00 | 0.00 | 136,020,000.00 | 136,020,000.00 | 14,476,150,000.00 | 9,504,770,000.00 | 110,900,000.00 | 0.00 | 0.00 | 2,533,040,000.00 | 6,324,730,000.00 | 354,350,000.00 | 5,970,380,000.00 | 462,610,000.00 | 4,971,380,000.00 | 221,380,000.00 | 1,970,310,000.00 | 81,700,000.00 | 1,888,610,000.00 | 833,970,000.00 | 1,643,210,000.00 | 0.00 | 0.00 | 137,960,000.00 | 1,505,250,000.00 | 38,751,880,000.00 | 29,140,370,000.00 | 200,800,000.00 | 0.00 | 2,951,030,000.00 | 142,860,000.00 | 0.00 | 142,860,000.00 | 0.00 | 21,554,560,000.00 | 18,236,070,000.00 | 3,318,490,000.00 | 4,224,630,000.00 | 0.00 | 4,224,630,000.00 | 577,180,000.00 | 3,647,450,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9,611,510,000.00 | 2,749,260,000.00 | 0.00 | 0.00 | 1,390,890,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 51,530,000.00 | 0.00 | 3,497,490,000.00 | 0.00 | 0.00 | 1,922,340,000.00 | 195,200,000.00 | 1,727,140,000.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 0.00 | 135,992,238.00 | 135,992,238.00 | 7,740,700,000.00 | 8,767,110,000.00 | -164,570,000.00 | 30,260,040,000.00 | 3,214,890,000.00 | -164,570,000.00 | 466,950,000.00 | 21,959,880,000.00 | 28,404,350,000.00 | 22,206,770,000.00 | 246,890,000.00 | 21,959,880,000.00 | 28,020,000.00 | 21,559,300,000.00 | 152,750,000.00 | 135,990,000.00 | 135,990,000.00 | 14,466,510,000.00 | 10,034,180,000.00 | 113,220,000.00 | 95,010,000.00 | 18,210,000.00 | 2,576,380,000.00 | 6,834,210,000.00 | 389,740,000.00 | 6,444,470,000.00 | 441,190,000.00 | 4,432,330,000.00 | 179,200,000.00 | 1,932,900,000.00 | 77,210,000.00 | 1,855,690,000.00 | 694,370,000.00 | 1,436,730,000.00 | 148,990,000.00 | 1,050,000.00 | 39,000,000.00 | 1,247,690,000.00 | 36,673,280,000.00 | 29,026,060,000.00 | 10,000.00 | 96,580,000.00 | 2,739,450,000.00 | 68,770,000.00 | 8,300,000.00 | 65,470,000.00 | 3,300,000.00 | 22,124,450,000.00 | 18,805,960,000.00 | 3,318,490,000.00 | 3,891,680,000.00 | -933,730,000.00 | 4,825,410,000.00 | 331,680,000.00 | 1,539,490,000.00 | 1,392,470,000.00 | 1,332,590,000.00 | 229,180,000.00 | 0.00 | 7,647,220,000.00 | 2,473,490,000.00 | 25,110,000.00 | 864,320,000.00 | 1,314,350,000.00 | 0.00 | 819,310,000.00 | 38,440,000.00 | 456,600,000.00 | 91,200,000.00 | 1,565,620,000.00 | 2,927,090,000.00 | -35,180,000.00 | 2,962,270,000.00 | 859,530,000.00 | 300,070,000.00 | 559,460,000.00 | 559,460,000.00 |
| 2023-03-31T00:00:00 | annual | 0.00 | 135,992,238.00 | 135,992,238.00 | 7,740,700,000.00 | 8,767,110,000.00 | -164,570,000.00 | 30,260,040,000.00 | 3,214,890,000.00 | -164,570,000.00 | 466,950,000.00 | 21,959,880,000.00 | 28,404,350,000.00 | 22,206,770,000.00 | 246,890,000.00 | 21,959,880,000.00 | 28,020,000.00 | 21,559,300,000.00 | 152,750,000.00 | 135,990,000.00 | 135,990,000.00 | 14,466,510,000.00 | 10,034,180,000.00 | 113,220,000.00 | 95,010,000.00 | 18,210,000.00 | 2,576,380,000.00 | 6,834,210,000.00 | 389,740,000.00 | 6,444,470,000.00 | 441,190,000.00 | 4,432,330,000.00 | 179,200,000.00 | 1,932,900,000.00 | 77,210,000.00 | 1,855,690,000.00 | 694,370,000.00 | 1,436,730,000.00 | 148,990,000.00 | 1,050,000.00 | 39,000,000.00 | 1,247,690,000.00 | 36,673,280,000.00 | 29,026,060,000.00 | 10,000.00 | 96,580,000.00 | 2,739,450,000.00 | 68,770,000.00 | 8,300,000.00 | 65,470,000.00 | 3,300,000.00 | 22,124,450,000.00 | 18,805,960,000.00 | 3,318,490,000.00 | 3,891,680,000.00 | -933,730,000.00 | 4,825,410,000.00 | 331,680,000.00 | 1,539,490,000.00 | 1,392,470,000.00 | 1,332,590,000.00 | 229,180,000.00 | 0.00 | 7,647,220,000.00 | 2,473,490,000.00 | 25,110,000.00 | 864,320,000.00 | 1,314,350,000.00 | 0.00 | 819,310,000.00 | 38,440,000.00 | 456,600,000.00 | 91,200,000.00 | 1,565,620,000.00 | 2,927,090,000.00 | -35,180,000.00 | 2,962,270,000.00 | 859,530,000.00 | 300,070,000.00 | 559,460,000.00 | 559,460,000.00 |
| 2022-03-31T00:00:00 | annual | 0.00 | 135,930,197.00 | 135,930,197.00 | 0.00 | 844,070,000.00 | 11,552,390,000.00 | 19,533,220,000.00 | 4,276,840,000.00 | 11,552,390,000.00 | 393,960,000.00 | 19,083,110,000.00 | 19,533,110,000.00 | 19,082,030,000.00 | -1,080,000.00 | 19,083,110,000.00 | 18,960,000.00 | 18,736,530,000.00 | 107,870,000.00 | 135,930,000.00 | 135,930,000.00 | 3,639,360,000.00 | 1,642,900,000.00 | 22,820,000.00 | 0.00 | 56,880,000.00 | 460,940,000.00 | 803,940,000.00 | 353,940,000.00 | 450,000,000.00 | 321,140,000.00 | 1,996,460,000.00 | 152,370,000.00 | 40,130,000.00 | 40,020,000.00 | 110,000.00 | 390,570,000.00 | 1,276,440,000.00 | 27,970,000.00 | 760,000.00 | 69,970,000.00 | 1,177,740,000.00 | 22,721,390,000.00 | 16,448,090,000.00 | 243,430,000.00 | 44,960,000.00 | 2,431,340,000.00 | 4,208,440,000.00 | 8,790,000.00 | 28,620,000.00 | 4,171,030,000.00 | 7,530,720,000.00 | 6,595,980,000.00 | 934,740,000.00 | 2,162,000,000.00 | -749,850,000.00 | 2,911,850,000.00 | 483,470,000.00 | 1,100,610,000.00 | 721,640,000.00 | 410,800,000.00 | 195,330,000.00 | 0.00 | 6,273,300,000.00 | 1,060,850,000.00 | 14,570,000.00 | 872,050,000.00 | 1,179,110,000.00 | 0.00 | 761,130,000.00 | 19,780,000.00 | 398,200,000.00 | 256,010,000.00 | 218,710,000.00 | 1,609,680,000.00 | -35,180,000.00 | 1,644,860,000.00 | 2,123,170,000.00 | 1,614,470,000.00 | 508,700,000.00 | 508,700,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 135,780,653.00 | 135,780,653.00 | 0.00 | 67,770,000.00 | 7,988,710,000.00 | 15,764,310,000.00 | 3,001,150,000.00 | 7,988,710,000.00 | 67,670,000.00 | 15,764,210,000.00 | 15,764,210,000.00 | 15,764,230,000.00 | 20,000.00 | 15,764,210,000.00 | 39,740,000.00 | 15,503,130,000.00 | 1,740,000.00 | 135,780,000.00 | 135,780,000.00 | 2,583,570,000.00 | 914,260,000.00 | 24,920,000.00 | 0.00 | 61,110,000.00 | 495,380,000.00 | 44,470,000.00 | 44,470,000.00 | 0.00 | 313,300,000.00 | 1,669,310,000.00 | 132,460,000.00 | 23,300,000.00 | 23,200,000.00 | 100,000.00 | 274,870,000.00 | 1,108,340,000.00 | 4,220,000.00 | 450,000.00 | 77,510,000.00 | 1,026,160,000.00 | 18,347,800,000.00 | 13,677,340,000.00 | 141,550,000.00 | 28,210,000.00 | 2,006,320,000.00 | 2,859,150,000.00 | 8,570,000.00 | 451,320,000.00 | 2,399,260,000.00 | 7,775,500,000.00 | 6,840,760,000.00 | 934,740,000.00 | 920,330,000.00 | -978,180,000.00 | 1,898,510,000.00 | 141,550,000.00 | 664,420,000.00 | 743,560,000.00 | 326,000,000.00 | 22,980,000.00 | 0.00 | 4,670,460,000.00 | 450,000.00 | 364,060,000.00 | 693,460,000.00 | 944,660,000.00 | 0.00 | 746,730,000.00 | 26,420,000.00 | 171,510,000.00 | 62,530,000.00 | 265,400,000.00 | 1,404,880,000.00 | -35,180,000.00 | 1,440,060,000.00 | 935,020,000.00 | 566,770,000.00 | 368,250,000.00 | 368,250,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,420,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: ERIS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repurchase Of Capital Stock | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Payments | Common Stock Issuance | Net Issuance Payments Of Debt | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Sale Of Business | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 3,568,430,000.00 | 0.00 | -1,593,990,000.00 | 16,230,980,000.00 | 45,430,000.00 | -1,291,630,000.00 | 942,450,000.00 | 269,610,000.00 | 560,220,000.00 | 112,620,000.00 | 13,797,790,000.00 | -102,800,000.00 | -772,970,000.00 | 0.00 | 0.00 | 45,430,000.00 | 0.00 | 45,430,000.00 | 14,636,990,000.00 | 14,636,990,000.00 | -1,593,990,000.00 | 16,230,980,000.00 | -18,545,230,000.00 | -12,123,090,000.00 | 69,940,000.00 | 0.00 | 484,060,000.00 | 484,060,000.00 | 0.00 | -5,668,000,000.00 | 0.00 | -5,668,000,000.00 | -1,291,630,000.00 | 0.00 | -1,291,630,000.00 | 0.00 | 4,860,060,000.00 | -1,007,540,000.00 | -987,390,000.00 | -958,740,000.00 | -162,200,000.00 | 909,780,000.00 | -169,400,000.00 | -570,930,000.00 | 773,390,000.00 | 7,500,000.00 | 0.00 | 1,826,050,000.00 | 1,270,730,000.00 | 555,320,000.00 | -93,760,000.00 | 21,420,000.00 | 8,000,000.00 | 4,312,390,000.00 |
| 2023-03-31T00:00:00 | annual | -5,496,830,000.00 | 0.00 | -3,500,000,000.00 | 11,678,000,000.00 | 22,780,000.00 | -8,414,210,000.00 | 560,220,000.00 | 74,900,000.00 | 508,700,000.00 | -23,380,000.00 | 6,880,250,000.00 | 0.00 | -234,300,000.00 | -999,110,000.00 | 0.00 | 22,780,000.00 | 0.00 | 22,780,000.00 | 8,178,000,000.00 | 8,178,000,000.00 | -3,500,000,000.00 | 11,678,000,000.00 | -9,821,010,000.00 | -5,150,000.00 | 40,760,000.00 | 0.00 | 4,904,390,000.00 | 5,204,390,000.00 | -300,000,000.00 | -6,554,910,000.00 | 0.00 | -6,554,910,000.00 | -8,412,840,000.00 | 1,370,000.00 | -8,414,210,000.00 | 0.00 | 2,917,380,000.00 | -772,080,000.00 | -1,755,360,000.00 | 21,150,000.00 | -764,590,000.00 | -104,970,000.00 | 47,440,000.00 | -1,171,380,000.00 | 225,920,000.00 | 31,210,000.00 | 1,990,000.00 | 1,170,880,000.00 | 826,580,000.00 | 344,300,000.00 | -71,320,000.00 | 20,180,000.00 | 18,860,000.00 | 4,046,430,000.00 |
| 2022-03-31T00:00:00 | annual | 2,572,310,000.00 | 0.00 | 0.00 | 450,010,000.00 | 71,960,000.00 | -1,210,330,000.00 | 508,700,000.00 | 0.00 | 369,150,000.00 | 139,550,000.00 | -446,990,000.00 | 780,000.00 | -38,500,000.00 | -816,230,000.00 | 0.00 | 71,960,000.00 | 0.00 | 71,960,000.00 | 450,010,000.00 | 450,010,000.00 | 0.00 | 450,010,000.00 | -3,196,100,000.00 | -960,000.00 | 50,280,000.00 | 0.00 | -1,881,860,000.00 | 795,870,000.00 | -2,677,730,000.00 | 0.00 | 0.00 | 0.00 | -1,202,750,000.00 | 7,580,000.00 | -1,210,330,000.00 | 0.00 | 3,782,640,000.00 | -832,850,000.00 | -299,010,000.00 | 27,110,000.00 | -146,870,000.00 | 151,590,000.00 | -234,450,000.00 | -204,800,000.00 | -43,030,000.00 | 13,550,000.00 | -1,520,000.00 | 647,050,000.00 | 449,280,000.00 | 197,770,000.00 | -166,090,000.00 | 42,540,000.00 | 0.00 | 4,421,980,000.00 |
| 2021-03-31T00:00:00 | annual | 3,495,980,000.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | -257,630,000.00 | 369,150,000.00 | 0.00 | 673,070,000.00 | -303,920,000.00 | -823,950,000.00 | 0.00 | -17,810,000.00 | -746,790,000.00 | -746,790,000.00 | 0.00 | 0.00 | 0.00 | 100,000.00 | 100,000.00 | 0.00 | 100,000.00 | -3,233,580,000.00 | -13,420,000.00 | 13,020,000.00 | 0.00 | -2,959,720,000.00 | 774,200,000.00 | -3,733,920,000.00 | 0.00 | 0.00 | 0.00 | -257,250,000.00 | 380,000.00 | -257,630,000.00 | 0.00 | 3,753,610,000.00 | -685,350,000.00 | 53,270,000.00 | 39,900,000.00 | 74,700,000.00 | 25,660,000.00 | -249,910,000.00 | 158,960,000.00 | -15,720,000.00 | 11,200,000.00 | 65,100,000.00 | 429,850,000.00 | 0.00 | 429,850,000.00 | -49,770,000.00 | 60,000.00 | 0.00 | 3,944,970,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | -1,016,770,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -469,790,000.00 | -469,790,000.00 | 0.00 | -1,016,770,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30,000.00 | 0.00 | 0.00 | -381,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,512,820,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: ERIS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Impairment Of Capital Assets | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.51 | 0.00 | 691.89 | 6.75 | 6.75 | 391.98 | 182.61 | 387.64 | 698.65 | 516.04 | -77.79 | 84.80 | 7.01 | 385.74 | 391.98 | 1,496.00 | 3.23 | 13.62 | 13.60 | 0.00 | 0.00 | 391.98 | 391.98 | 0.00 | 391.98 | -5.07 | 397.05 | 397.05 | 34.19 | 431.24 | 5.12 | -2.62 | 2.14 | 0.48 | 0.00 | -77.79 | 0.00 | 84.80 | 7.01 | 495.30 | 1,108.36 | 271.32 | 182.61 | 127.07 | 55.53 | 5.72 | 250.41 | 178.93 | 71.48 | 3.23 | 1,603.66 | 387.64 | 1,991.30 | 1,991.30 |
| 2023-03-31T00:00:00 | annual | 0.38 | 0.00 | 542.82 | 5.08 | 5.08 | 382.16 | 117.09 | 357.08 | 547.90 | 430.81 | -23.87 | 26.17 | 2.30 | 377.46 | 382.16 | 1,239.63 | 2.22 | 13.62 | 13.60 | 0.00 | 0.00 | 382.16 | 382.16 | 0.00 | 382.16 | 8.00 | 374.16 | 374.16 | 30.48 | 404.64 | 1.24 | -2.06 | 2.01 | 0.05 | 0.00 | -23.87 | 0.18 | 26.17 | 2.30 | 422.19 | 882.55 | 224.74 | 117.09 | 82.66 | 34.43 | 6.10 | 205.45 | 158.27 | 47.18 | 2.22 | 1,304.74 | 357.08 | 1,661.82 | 1,661.82 |
| 2022-03-31T00:00:00 | annual | 1.17 | 0.00 | 496.83 | 14.22 | 14.22 | 406.11 | 64.71 | 260.81 | 511.05 | 446.34 | 1.88 | 4.15 | 6.10 | 393.06 | 406.11 | 901.11 | 3.25 | 13.59 | 13.59 | 0.00 | 0.00 | 406.11 | 406.11 | 0.00 | 406.11 | 0.32 | 405.79 | 405.79 | 36.41 | 442.20 | 1.04 | -2.39 | 2.39 | 0.00 | 0.00 | 1.88 | 0.07 | 4.15 | 6.10 | 425.06 | 640.30 | 153.89 | 64.71 | 0.00 | 64.71 | 32.74 | 152.06 | 101.65 | 50.41 | 3.25 | 1,065.36 | 260.81 | 1,326.17 | 1,326.17 |
| 2021-03-31T00:00:00 | annual | 0.50 | 0.00 | 434.33 | 4.96 | 4.96 | 355.14 | 42.99 | 241.87 | 439.28 | 396.30 | 0.31 | 1.80 | 2.29 | 350.67 | 355.14 | 803.87 | 2.11 | 13.59 | 13.58 | 0.00 | 0.00 | 355.14 | 355.14 | 0.00 | 355.14 | 0.00 | 355.14 | 355.14 | 39.36 | 394.50 | 0.46 | -0.02 | 0.02 | 0.00 | 0.02 | 0.31 | 0.17 | 1.80 | 2.29 | 388.77 | 562.00 | 149.33 | 42.99 | 0.00 | 42.99 | 5.09 | 151.12 | 108.08 | 43.04 | 2.11 | 950.78 | 241.87 | 1,192.64 | 1,192.64 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.74 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
25.54
P/E
52.638996
P/B
6.6016197
Dividend Yield
N/A
Market Cap
18,301.18 Cr.
Face Value
203.647
Book Value
203.647
ROE
14.02%
EBITDA Growth
826.18 Cr.
Debt/Equity
86.078
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of eris?
The market capitalization of Eris Lifesciences Limited is ₹18,301 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Eris Lifesciences Limited?
The PE and PB ratios of Eris Lifesciences Limited are Not Available and 6.6016197 respectively as of 05 Feb 2025.
What is the 52 Week High of Eris Lifesciences Limited?
The 52-week high of Eris Lifesciences Limited is ₹1593.9 as of 05 Feb 2025.
What is the 52 Week Low of Eris Lifesciences Limited?
The 52-week low of Eris Lifesciences Limited is ₹809.15 as of 05 Feb 2025.
What are the earnings per share (EPS) for Eris Lifesciences Limited?
The Earnings Per Share (EPS) of Eris Lifesciences Limited is ₹25.54 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Eris Lifesciences Limited?
The Return on Equity (ROE) of Eris Lifesciences Limited is 14.02% as per the most recent financial year data. Explore more on Fincept.